middle.news
Optiscan Launches Pioneering Breast Cancer Imaging Study at Royal Melbourne
1:42pm on Monday 30th of June, 2025 AEST
•
Healthcare
Read Story
Optiscan Launches Pioneering Breast Cancer Imaging Study at Royal Melbourne
1:42pm on Monday 30th of June, 2025 AEST
Key Points
First in-human breast cancer study initiated using InVue® and InForm™ devices
Recruitment of 50 patients undergoing breast-conserving surgery underway at Royal Melbourne Hospital
Real-time in vivo imaging aims to improve surgical margin assessment during lumpectomy
Ex vivo digital pathology imaging complements live surgery data for comprehensive analysis
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Optiscan Imaging (ASX:OIL)
OPEN ARTICLE